December 2, 2025
November 26, 2025
Today our COO Ingrid de Visser-Kamerling was live on the BNR Nieuwsradio with Koenraad Wiedhaup to talk about the recent developments in infectious disease…
November 25, 2025
Leiden, 26 November 2025 – INFECTA, a Dutch clinical research organization specializing in infectious diseases, has signed a collaboration agreement with AHAM Vastgoed for…
November 4, 2025
Celebrating our 1 year anniversary at the first FAST – Centre for Future Affordable Sustainable Therapy Development event today with cake!
…October 21, 2025
Today, our CEO Meta Roestenberg was live on BNR Zakendoen! In the interview, she outlined INFECTA’s approach: to accelerate the development of vaccines and…
October 15, 2025
This afternoon, our COO Ingrid de Visser-Kamerling gave a presentation at The World Vaccine Congress about the advantages and impact of using Controlled Human…
July 14, 2025
On Thursday 10 July, our COO Ingrid de Visser-Kamerling took part in a panel discussion during the PLNT Leiden Festival titled “What will the…
Clostridioides difficile (C. difficile) remains a major cause of healthcare-associated diarrhoea, with rising antibiotic resistance and frequent relapses making treatment increasingly difficult. While faecal…
In this study schistosomiasis research is boosted by developing the first controlled human infection model using female-only Schistosoma mansoni parasites. This innovative approach aims…
July 4, 2025
Yes, we did it! Cheers to our partnership! 🥂 Last Friday, we signed the Master Service Agreement between Centre for Human Drug Research (CHDR)…
